Based on these observations, it can be hypothesized that MMC, an alkylating agent, can directly trigger pulmonary vascular dysfunction via DNA damage signaling, and that a similar mechanism may underlie familial PVOD/PCH with biallelic inactivation of EIF2AK4 (Figure 2). The gene discussed is EIF2AK4; the disease is pulmonary venoocclusive disease.